glutamine has been researched along with Chronic Hepatitis B in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QH; Huang, J; Huang, YH; Jiang, CH; Liang, LX; Song, HY; Yang, JR | 1 |
| Hirayama, A; Honma, M; Igarashi, K; Ikeda, S; Kashikura, K; Kawata, S; Mori, M; Nihei, K; Otsuka, M; Saito, T; Sakuragawa, T; Soga, T; Suematsu, M; Sugimoto, M; Suzuki, H; Tomita, M; Tsuji, S; Watanabe, H; Yamamoto, T; Yatomi, Y; Yoshida, H | 1 |
| Cho, SG; Choi, W; Hong, KC; Kim, HJ; Kim, MY; Kim, YB; Kim, YS; Lee, JH; Shin, SH; Suh, CH | 1 |
2 trial(s) available for glutamine and Chronic Hepatitis B
| Article | Year |
|---|---|
[The change of intestinal mucosa barrier in chronic severe hepatitis B patients and clinical intervention].
Topics: Administration, Oral; Adolescent; Adult; Amine Oxidase (Copper-Containing); Antiviral Agents; Child; Endotoxins; Female; Glutamine; Hepatitis B, Chronic; Humans; Intestinal Mucosa; Intestine, Small; Lactulose; Male; Mannitol; Middle Aged; Permeability; Treatment Outcome; Young Adult | 2009 |
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
Topics: Aged; Biomarkers; Carcinoma, Hepatocellular; Diagnosis, Differential; Dipeptides; Fatty Liver; Female; Glutamine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protein Array Analysis; Reproducibility of Results | 2011 |
1 other study(ies) available for glutamine and Chronic Hepatitis B
| Article | Year |
|---|---|
Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.
Topics: Adolescent; Adult; Biopsy; Female; Glucose; Glutamic Acid; Glutamine; Glycogen; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lipids; Liver; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates | 2001 |